Work

Development and Validation of a UHPLC-MS/MS Method to Identify Interference from Qiliqiangxin Capsule and Deslanoside in Digoxin Therapeutic Drug Monitoring: A Comparison with Immunoassay

FWCI:
Cites: 18
Cited by:
Related to: